CapsoVision (CV) Asset Utilization Ratio (2025)

CapsoVision's (CV) quarterly Asset Utilization Ratio came in at 0.65 in Q4 2025, down 13.9% quarter-over-quarter from 0.75 in Q3 2025.

CapsoVision (CV) Asset Utilization Ratio (2025) Analysis & Trends

CapsoVision has disclosed Asset Utilization Ratio across 1 years of filings, most recently posting 0.65 for Q4 2025.

Asset Utilization Ratio for Q4 2025 came in at 0.65, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.65 (changed N/A YoY), and the FY2025 annual result was 0.78, changed N/A from the prior year.
Asset Utilization Ratio came in at 0.65 for Q4 2025 at CapsoVision, down from 0.75 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 0.95 in Q2 2025 to a low of 0.65 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	0.46
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	0.54
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	0.39
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	0.47
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	0.47
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	0.57
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.65
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	0.74
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	0.56
10	CapsoVision	176.55 Mn	166.44 Mn	1.95 Mn	0.65

Download Data